The Antiphospholipid Syndrome
Apl de aps hi-res stock photography and images - Alamy
Antiphospholipid Syndrome – Synapse
Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses | Arteriosclerosis, Thrombosis, and Vascular Biology
IJMS | Free Full-Text | Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome
Thrombocytopenia predicts thrombosis risk, poor survival in antiphospholipid syndrome
Flow diagram of study design. aPL: Antiphospholipid antibodies; APS:... | Download Scientific Diagram
The antiphospholipid syndrome – often overlooked cause of vascular occlusions? - Svenungsson - 2020 - Journal of Internal Medicine - Wiley Online Library
Laurent ARNAUD sur Twitter : "Discover the pathogenesis of the #antiphospholipid syndrome #APS and the effect of low-dose asprin in patients with aPL. https://t.co/mfzO3tyanh https://t.co/eOn4uUTavF" / Twitter
Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases? | Nature Reviews Rheumatology
Prothrombotic Antiphospholipid Antibodies in COVID-19 - ACR Meeting Abstracts
IJMS | Free Full-Text | Understanding the Pathophysiology of Thrombotic APS through Animal Models
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 | Science Translational Medicine
Laurent ARNAUD on Twitter: "❤️ EULAR recommendations for the management of #cardiovascular risk in patients with #lupus or aPL/APS 🎯 Link: https://t.co/AxsCpTXgcn https://t.co/tnsarpvrXu" / Twitter
Antiphospholipid (APL / APS) / Hughes syndrome | Facebook
Frontiers | Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation
Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management | Semantic Scholar
The distribution of aPL biomarker reactivity in (A) APS/non-APS... | Download Scientific Diagram
Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics - ScienceDirect
